Coiante Scott M Insider Trades

Insider Trading History

Track insider trading activity for Coiante Scott M. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Svp, Chief Financial Officer
Holding Value $593k 320,473 shares
Last Trade
Feb 28, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$236k 160,237 shares
$1.47
$1.85
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Svp, Chief Financial Officer
Holding Value $296k 160,237 shares
Last Trade
Feb 28, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$236k 160,237 shares
$1.47
$1.85
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Svp, Chief Financial Officer
Holding Value $195k 105,356 shares
Last Trade
Feb 28, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$80.7k 54,881 shares
$1.47
$1.85
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Svp, Chief Financial Officer
Holding Value $757k 409,020 shares
Last Trade
Feb 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$893k 681,700 shares
$1.31
$1.85
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Svp, Chief Financial Officer
Holding Value $1.33M 721,070 shares
Last Trade
Feb 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$891k 1,201,780 shares
$0.74
$1.85
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Svp, Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jan 02, 2025 Sale
$170k 230,000 shares
$0.74
$1.85
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Svp, Chief Financial Officer
Holding Value $426k 230,000 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$170k 230,000 shares
$0.74
$1.85
Agile Therapeutics
Agile Therapeutics AGRX
Chief Financial Officer
Holding Value $7.67k 5,080 shares
Last Trade
Aug 26, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$30.5k 20,080 shares
$1.52
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Chief Financial Officer
Holding Value $30.3k 20,080 shares
Last Trade
Oct 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42k 20,000 shares
$2.10
$1.51
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Financial Officer
Holding Value $111k 145,065 shares
Last Trade
Jul 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.27M 150,000 shares
$21.80
$0.76
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Financial Officer
Holding Value $64.2k 84,265 shares
Last Trade
Jun 03, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$587k 35,284 shares
$16.63
$0.76
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Financial Officer
Holding Value $142k 185,900 shares
Last Trade
Mar 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.33M 228,800 shares
$36.40
$0.76
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Financial Officer
Holding Value $58.4k 76,649 shares
Last Trade
Feb 25, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$516k 14,817 shares
$34.80
$0.76
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Financial Officer
Holding Value $69.7k 91,466 shares
Last Trade
Aug 25, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$600k 7,534 shares
$79.60
$0.76
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Financial Officer
Holding Value $27.1k 35,500 shares
Last Trade
Feb 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.2M 143,000 shares
$120.00
$0.76
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Financial Officer
Holding Value $41.9k 55,000 shares
Last Trade
Mar 24, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.1M 55,000 shares
$710.00
$0.76
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Financial Officer
Holding Value $41.9k 55,000 shares
Last Trade
Mar 24, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.1M 55,000 shares
$710.00
$0.76
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Financial Officer
Holding Value $115k 150,824 shares
Last Trade
Oct 07, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$61.1M 150,824 shares
$405.00
$0.76
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Financial Officer
Holding Value $1.91k 2,500 shares
Last Trade
Oct 07, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.01M 2,500 shares
$405.00
$0.76
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Oct 02, 2019 Sale
No data
No data
$0.76

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up